Volume 4, Issue 2 (Autumn & Winter 2016 2017)                   Jorjani Biomed J 2017, 4(2): 34-47 | Back to browse issues page

XML Persian Abstract Print

1- Department of Microbiology, Science and Research Ayatollah Amoli Branch, Islamic Azad University, Amol, Iran , m.zaboli1379@yahoo.com
2- Department of Biology, Science and Research Ayatollah Amoli Branch, Islamic Azad University, Amol, Iran
Abstract:   (2618 Views)

Background and Objectives: Escherichia coli (E.coli) is one of the most common bacteria causing urinary tract infections which has become resistant to beta-lactam antibiotics due to the acquisition of plasmids encoding extended-spectrum beta-lactamases (ESBL). Here, we investigated the phenotype and genotype of Cefotaxsim-M (CTX-M) gene among ESBL-producing Escherichia coli among urine samples of patients reffering to Yahyanejad hospital of Babol city.

Methods: The present cross-sectional study was conducted among all 1842 patients referring to Yahyanejad hospital since June to December of 2015. Disc diffusion method was used to evaluate the bacterial resistance to cefotaxime, meropenem, gentamicin, amikacin, ciprofloxacin, ceftriaxone, nitrofurantoin and nalidixic acid. The resistant strains were also confirmed using a combination of cefotaxime-clavulanic acid and ceftazidime-clavulanic acid discs. The presence of CTX-M gene was evaluated among ESBL-producing strains by Real time PCR. SPSS 20 software and chi-square test were used to analyze data statistically.

Results: A total of 84 E.coli isolates were detected in all specimens. The most sensitivities were against amikacin (91.67%), meropenem (96.43%), ampicillin/sulbactam (95.24%) and  piperacillin/tazobactam (94.5%). However, the highest resistancies were against nalidixic acid (83%) , doxycycline/ salicilin (70%), ceftriaxone (46.63 %) and ciprofloxacin (51.2%). Twenty-nine isolates (34.5%) produced ESBL. The CTX-M positive ESBL-producing E-coli was 69%. There was a significant relationship between the presence of CTX-M gene and ESBL (P-value = 0.03).

Conclusion: In the present study, the presence of beta-lactamase-producing genes (CTX-M) in E.coli strains were markedly high. Therefore, the consumption of antibiotics should be controled and further phenotypic and genotypic studies on bacterial pathogens should be conducted.

Full-Text [PDF 917 kb]   (890 Downloads)    
Type of Article: Original article | Subject: General medicine
Received: 2016/12/26 | Revised: 2017/09/6 | Accepted: 2016/12/26 | Published: 2016/12/26

1. Sanchez UM, Bello TH, Dominguez YM, Mella MS, Zemelman ZR, Gonzalez RG. [Transference of extended-spectrum beta-lactamases from nosocomial strains of Klebsiella pneumoniae to other species of Enterobacteriaceae]. Rev Med Chil. 2006;134(4):415-20
2. Davies J, Davies D. Origins and evolution of antibiotic resistance. Microbiol Mol Biol Rev. 2010;74(3):417–33
3. Livermore DM. beta-Lactamases in laboratory and clinical resistance. Clin Microbiol Rev. 1995; 8 (4): 557-84
4. Li Q, Lee JY, Castillo R, Hixon MS, Pujol C, Doppalapudi VR, et al. NB2001, a novel antibacterial agent with broad-spectrum activity and enhanced potency against beta-lactamase-producing strains. Antimicrob Agents Chemother. 2002;46(5):1262-8
5. Tenover FC, Raney PM, Williams PP, Rasheed JK, Biddle JW, Oliver A, et al. Evaluation of the NCCLS extended-spectrum beta-lactamase confirmation methods for Escherichia coli with isolates collected during Project ICARE. J Clin Microbiol. 2003;41(7):3142-6
6. Medeiros A, Mayer KH, Opal S. Plasmid mediated beta-lactamases. The Antimicrobic Newsletter 1988;5(9):61-2
7. Bush K, Jacoby GA. Updated functional classification of β-lactamases. Antimicrob Agents Chemother. 2010;54(3):969–76
8. Bonnedahl J, Drobni M, Gauthier-Clerc M, Hernandez J, Granholm S, Kayser Y, et al. Dissemination of Escherichia coli with CTX-M type ESBL between humans and yellow-legged gulls in the south of France. PLoS One. 2009;4(6):e5958
9. Livermore DM, Canton R, Gniadkowski M, Nordmann P, Rossolini GM, Arlet G, et al. CTX-M: changing the face of ESBLs in Europe. J Antimicrob Chemother. 2007;59(2):165-74
10. Mirzaee m, Pourmand MR, Chitsaz M, Mansouri S. Antibiotic resistance to third generation cephalosporins due to CTX-M-Type extended-spectrum β-Lactamases in clinical isolates of escherichia coli. Iranian J PublHealth. 2009;38(1):10-7
11. Kim YK, Pai H, Lee HJ, Park SE, Choi EH, Kim J, et al. Bloodstream infections by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in children: epidemiology and clinical outcome. Antimicrobial agents and chemotherapy. 2002;46(5):1481-91
12. Honarm H, Falah Ghavidel M, Nikokar I, Rahbar Taromsari M. Evaluation of a PCR assay to detect enterococcusfaecalis in blood and determine glycopeptides resistance genes: van a and van B. Iranian journal of medical sciences. 2012;37(3):194-9
13. Sagh H, Soroshniya M. Comprehensive reference laboratory equipment and products Tehran: Cultural agency Mir 2003
14. Sturenburg E, Mack D. Extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory, therapy, and infection control. The Journal of infection. 2003;47(4):273-95
15. Calbo E, Freixas N, Xercavins M, Riera M, Nicolas C, Monistrol O, et al. Foodborne nosocomial outbreak of SHV1 and CTX-M-15-producing Klebsiella pneumoniae: epidemiology and control. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2011;52(6):743-9
16. VanGuilder HD, Vrana KE, Freeman WM. Twentyfive years of quantitative PCR for gene expression analysis.Biotechniques. 2008; 44(5): 619-626
17. Arbeloa A, Oates CV, Marches O, Hartland EL, Frankel G. Enteropathogenic and enterohemorrhagic Escherichia coli type III secretion effector EspV induces radical morphological changes in eukaryotic cells. Infection and immunity. 2011;79(3):1067-76
18. Bouzari S, Jafari A, Azizi A, Oloomi M, Nataro JP. Short report: characterization of enteroaggregative Escherichia coli isolates from Iranian children. The American journal of tropical medicine and hygiene. 2001;65(1):13-4
19. Norouzi J, Kargar M, Pourshahin F, Kamali S. Study on the prevalence of urinary tract infection by escherichia coli antibiotic resistance and plasmid profile of isolated bacteria .in Jahrom city. J Army Uni Med Sci. 2006;4(13):745-9
20. Novakova I, Kacaniova M, Hascik P, Pavlcova S, Hleba L. The resistance to antibiotics in strains of E. coli and enteenterococcus sp. Isolated from rectal swabs of lambs and calves. J Lucraristiintificezootehniesibiotehno. 2009;42(2):322-6
21. Soltan Dallal MM, Azarsa M, Shirazi MH, Rastegar Lari A, Owlia P, Fallah Mehrabadi J, et al. The prevalence of extended-spectrum beta-lactamases and CTX-M-1 producing escherichia coli in urine samples collected at Tabriz city Hospitals. Tehran Univ Med J. 2011;69(5):273-8
22. Mansouri S, Abbasi S. Prevalence of multiple drug resistant clinical isolates of extendedspectrum beta-lactamase producing enterobacteriaceae in southeast Iran. Iranian Journal of Medical Sciences. 2010;35(2):101-8
23. Shayanfar N, Rezaei M, Ahmadi M, Ehsanipour F. Evaluation of extended spectrum beta lactamase (ESBL) positive strains of Klebsiella pneumoniae and Escherichia coli in bacterial cultures. Iran J Pathol. 2010;5(1):34-9
24. Barati L, Ghezelsofla F, Azarhoush R, Heidari F, Noura M. Antibiotic sensitivity of isolated E.coli from pregnant women urine. J Gorgan Uni Med Sci. 2011;13(3):101-7
25. MohamadiMehr M, Faizabadi MM, Bahadori O. Antibiotic resistance patterns of gram-negative bacilli responsible for nosocomial infections in hospital intensive care department of family and Golestan Tehran 2007. J Army Uni Med Sci. 2010;8(4):283-90
26. Mohamadi M. Survey Antibiotic susceptibility of bacterial strains isolated from urinary tract infections. Islamic Azad Uni J Med Sci. 2006;16(2):95-9
27. Mohajeri P, Izadi B, Rezai M, Falahi B, Khademi H, Ebrahimi R. Assessment of the frequency of Extended Spectrum Beta Lactamases Producing Escherichiacoli Isolated from Urinary Tract Infections and its Antibiotic Resistance Pattern in Kermanshah. J Ardabil Uni Med Sci. 2011;11(1):86-94
28. Madani SH, Khazaee S, Kanani M, Shahi M. Antibiotic resistance pattern of E.coli isolated from urine culture in Imam Reza Hospital Kermanshah-2006. J Kermanshah Uni Med Sci. 2008;12(3):287-95
29. Horcajada JP, Soto S, Gajewski A, Smithson A, Jimenez de Anta MT, Mensa J, et al. Quinolone-resistant uropathogenic Escherichia coli strains from phylogenetic group B2 have fewer virulence factors than their susceptible counterparts. Journal of clinical microbiology. 2005;43(6):2962-4
30. Fazeli H, Hoseini M M, Mohammadi Ghalaei P. Frequency and resistance pattern of extended spectrum beta lactamase producing Escherichia coli in clinical specimen of Alzahra hospital in Isfahan, Iran, 2007. J Shahrekord Univ Med Sci. 2009; 10 (4) :58-64
31. Goyal A, Prasad KN, Prasad A, Gupta S, Ghoshal U, Ayyagari A. Extended spectrum beta-lactamases in Escherichia coli & Klebsiella pneumoniae & associated risk factors. The Indian journal of medical research. 2009;129(6):695-700
32. Shahid M, Singhal M, Malik A, Jain A, Mondal M. Prevalence & antimicrobial resistance pattern of extended spectrum β- lactamase producing Klebsiella spp isolated from cases of neonatal septicaemia. Indian J Med Res. 2007;125(1):89-94
33. Zamani K, Emami A, Bazargani A, Moattari A. Phenotypic and molecular characterization of CTX-M extended-spectrum beta-lactamase-producing Escherichia coli isolates in Shiraz, Iran. Shiraz University of Medical Sciences. 2015; 48(4):479-482
34. Cankar K, Stebih D, Dreo T, Zel J, Gruden K. Critical points of DNA quantification by real-time PCR-effects of DNA extraction method and sample matrix on quantification of genetically modified organisms. BMC Biotechnol. 2006;6:37